BioLineRx (BLRX) Short Interest Ratio & Short Volume $3.18 -0.02 (-0.63%) Closing price 03/7/2025 04:00 PM EasternExtended Trading$3.18 +0.00 (+0.16%) As of 03/7/2025 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends BioLineRx Short Interest DataBioLineRx (BLRX) has a short interest of 216,400 shares, representing 5.85% of the float (the number of shares available for trading by the public). This marks a 76.08% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 64,670 shares to cover all short positions.Current Short Interest216,400 sharesPrevious Short Interest122,900 sharesChange Vs. Previous Month+76.08%Dollar Volume Sold Short$802,844.00Short Interest Ratio1.0 Days to CoverLast Record DateFebruary 15, 2025Outstanding Shares3,329,000 sharesFloat Size3,700,000 sharesShort Percent of Float5.85%Today's Trading Volume23,823 sharesAverage Trading Volume64,670 sharesToday's Volume Vs. Average37% Short Selling BioLineRx? Sign up to receive the latest short interest report for BioLineRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBLRX Short Interest Over TimeBLRX Days to Cover Over TimeBLRX Percentage of Float Shorted Over Time Remove Ads BioLineRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/15/2025216,400 shares $802,844.00 +76.1%5.9%1 $3.71 1/31/2025122,900 shares $437,524.00 -90.3%3.3%0.6 $3.56 1/15/20251,260,000 shares $5.27 million +53.3%N/A0.2 $4.18 12/31/2024822,200 shares $175,950.80 -0.7%N/A0.2 $0.21 12/15/2024827,800 shares $186,172.22 -10.2%N/A0.8 $0.22 11/30/2024921,900 shares $276,570.00 -16.2%N/A1.1 $0.30 11/15/20241,100,000 shares $523,160.00 +3.8%N/A1.6 $0.48 10/31/20241,060,000 shares $434,600.00 +70.6%N/A3.5 $0.41 10/15/2024621,400 shares $271,924.64 +351.3%N/A2.2 $0.44 9/30/2024137,700 shares $73,820.97 -23.2%N/A0.5 $0.54 Get the Latest News and Ratings for BLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioLineRx and its competitors with MarketBeat's FREE daily newsletter. 9/15/2024179,200 shares $111,301.12 +28.7%N/A0.7 $0.62 8/31/2024139,200 shares $90,048.48 -47.9%N/A0.5 $0.65 8/15/2024267,200 shares $181,241.76 -3.3%N/A0.8 $0.68 7/31/2024276,400 shares $217,084.56 +130.9%N/A0.8 $0.79 7/15/2024119,700 shares $90,972.00 -63.1%N/A0.3 $0.76 6/30/2024324,300 shares $184,818.57 +52.9%N/A0.9 $0.57 6/15/2024212,100 shares $141,661.59 -40.5%N/A0.5 $0.67 5/31/2024356,200 shares $265,582.72 +62.6%N/A0.8 $0.75 5/15/2024219,100 shares $135,173.75 -46.6%N/A0.5 $0.62 4/30/2024410,600 shares $274,855.64 -47.6%N/A1 $0.67 4/15/2024783,600 shares $504,560.04 +32.5%N/A1.8 $0.64 3/31/2024591,500 shares $662,480.00 +82.2%N/A1.6 $1.12 3/15/2024324,700 shares $373,405.00 +76.6%N/A1 $1.15 2/29/2024183,900 shares $244,587.00 -8.1%N/A0.6 $1.33 2/15/2024200,000 shares $221,000.00 -19.7%N/A0.7 $1.11 1/31/2024249,100 shares $296,429.00 -4.7%N/A0.8 $1.19 1/15/2024261,500 shares $368,715.00 +16.1%N/A0.8 $1.41 12/31/2023225,200 shares $353,564.00 +96.2%N/A0.6 $1.57 12/15/2023114,800 shares $182,532.00 -59.2%N/A0.3 $1.59 11/30/2023281,100 shares $407,595.00 -21.3%N/A0.3 $1.45 11/15/2023357,300 shares $603,837.00 -27.2%N/A0.3 $1.69 10/31/2023490,600 shares $735,900.00 -52.4%N/A0.4 $1.50 10/15/20231,030,000 shares $1.65 million -59.8%N/A0.9 $1.60 9/30/20232,560,000 shares $4.66 million -42.7%N/A2.2 $1.82 9/15/20234,470,000 shares $8.72 million +86.3%N/A4.1 $1.95 8/31/20232,400,000 shares $4.20 million +2.6%N/A2.6 $1.75 8/15/20232,340,000 shares $3.49 million +9.9%N/A6.2 $1.49 7/31/20232,130,000 shares $3.28 million -14.8%N/A4.9 $1.54 7/15/20232,500,000 shares $4.18 million +8.2%N/A5.6 $1.67 6/30/20232,310,000 shares $3.68 million +0.9%N/A4.9 $1.60URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now 6/15/20232,290,000 shares $4.05 million +19.3%N/A4.6 $1.77 5/31/20231,920,000 shares $3.02 million -1.5%N/A3.8 $1.58 5/15/20231,950,000 shares $2.69 million +69.6%N/A4 $1.38 4/30/20231,150,000 shares $1.23 million +21.3%N/A3.1 $1.07 4/15/2023948,300 shares $1.04 million +70.6%N/A2.8 $1.10 3/31/2023556,000 shares $492,894.00 +546.5%N/A1.8 $0.89 3/15/202386,000 shares $52,374.00 +9.7%N/A0.3 $0.61 2/28/202378,400 shares $46,648.00 -64.7%N/A0.3 $0.60 2/15/2023222,100 shares $137,702.00 +97.3%N/A0.9 $0.62 1/31/2023112,600 shares $70,926.74 -42.1%N/A0.3 $0.63 1/15/2023194,600 shares $134,488.06 +9.8%N/A0.6 $0.69 12/30/2022177,200 shares $104,548.00 +22.6%N/A0.5 $0.59 12/15/2022144,500 shares $92,248.80 -11.1%N/A0.4 $0.64 11/30/2022162,500 shares $114,546.25 -37.6%N/A0.4 $0.70 11/15/2022260,200 shares $176,936.00 +7.3%N/A0.7 $0.68 10/31/2022242,500 shares $205,446.00 +33.4%N/A0.9 $0.85 10/15/2022181,800 shares $152,712.00 +127.8%N/A0.7 $0.84 9/30/202279,800 shares $73,815.00 -80.5%N/A0.3 $0.93 9/15/2022408,300 shares $649,197.00 +17.3%N/A1.9 $1.59 8/31/2022348,200 shares $529,264.00 -20.7%N/A2.7 $1.52 8/15/2022439,000 shares $838,490.00 +14.3%N/A3.5 $1.91 7/31/2022384,000 shares $506,880.00 -6.6%N/A2.8 $1.32 7/15/2022411,200 shares $551,008.00 +14.8%N/A2.7 $1.34 6/30/2022358,100 shares $458,368.00 +3.7%N/A2.2 $1.28 6/15/2022345,400 shares $466,290.00 -18.1%N/A2 $1.35 5/31/2022421,800 shares $658,008.00 -11.7%N/A2.3 $1.56 5/15/2022477,400 shares $572,880.00 +30.8%N/A2.3 $1.20 4/30/2022365,000 shares $445,300.00 -9.5%N/A1.8 $1.22 4/15/2022403,300 shares $621,082.00 -20.8%N/A2 $1.54 3/31/2022509,200 shares $870,732.00 -11.3%N/A2.1 $1.71 3/15/2022574,100 shares $878,373.00 +14.7%N/A2 $1.53 2/28/2022500,700 shares $761,064.00 -6.1%N/A1.2 $1.52 2/15/2022533,400 shares $938,784.00 +25.9%N/A1.2 $1.76 1/31/2022423,800 shares $771,316.00 +6.5%N/A0.9 $1.82 1/15/2022398,100 shares $800,181.00 +21.4%N/A0.9 $2.01 12/31/2021328,000 shares $669,120.00 +19.5%N/A0.6 $2.04 12/15/2021274,600 shares $648,056.00 +135.3%N/A0.6 $2.36 11/30/2021116,700 shares $306,921.00 -36.8%N/A0.3 $2.63 11/15/2021184,500 shares $527,670.00 +18.0%N/A0.5 $2.86 10/29/2021156,400 shares $444,176.00 -54.1%N/A0.4 $2.84 10/15/2021340,700 shares $1.04 million +65.3%N/A0.8 $3.06 9/30/2021206,100 shares $566,775.00 +8.5%N/A0.4 $2.75 9/15/2021190,000 shares $513,000.00 -34.7%N/A0.2 $2.70 8/31/2021291,000 shares $835,170.00 +5.0%N/A0.3 $2.87 8/13/2021277,100 shares $836,842.00 +3.2%N/A0.3 $3.02 7/30/2021268,500 shares $867,255.00 +228.2%N/A0.2 $3.23 7/15/202181,800 shares $273,212.00 -27.2%N/A0 $3.34 6/30/2021112,300 shares $315,563.00 -64.8%N/A0 $2.81 6/15/2021319,100 shares $890,289.00 -50.7%N/A0.1 $2.79 5/28/2021647,600 shares $1.85 million +15.8%N/A0.1 $2.86URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now 5/14/2021559,500 shares $1.59 million +27.6%N/A0.1 $2.85 4/30/2021438,500 shares $1.34 million +9.3%N/A0.1 $3.05 4/15/2021401,200 shares $1.10 million -3.0%N/A0.3 $2.73 3/31/2021413,400 shares $1.17 million -7.0%N/A0.2 $2.82 3/15/2021444,600 shares $1.35 million -34.2%N/A0.2 $3.03 2/26/2021675,400 shares $2.18 million -62.5%N/A0.3 $3.23 2/12/20211,800,000 shares $6.68 million +0.6%N/A0.7 $3.71 1/29/20211,790,000 shares $5.24 million -27.8%N/A0.7 $2.93 1/15/20212,480,000 shares $6.94 million +0.8%N/A0.4 $2.80 12/31/20202,460,000 shares $6.27 million -2.4%N/A0.4 $2.55 12/15/20202,520,000 shares $8.54 million +11.5%N/A0.5 $3.39 11/30/20202,260,000 shares $5.24 million -8.9%N/A0.5 $2.32 11/15/20202,480,000 shares $5.83 million +79.7%N/A0.5 $2.35 10/30/20201,380,000 shares $2.04 million -8.0%N/A0.3 $1.48 10/15/20201,500,000 shares $2.41 million No ChangeN/A6.1 $1.61 9/30/20201,500,000 shares $2.46 million -1.3%N/A4.5 $1.64 9/15/20201,520,000 shares $2.64 million -1.3%N/A4.2 $1.74 8/31/20201,540,000 shares $2.80 million -7.2%N/A3.5 $1.82 8/14/20201,660,000 shares $3.40 million +12.2%N/A2.3 $2.05 7/31/20201,480,000 shares $3.36 million +114.6%N/A2.1 $2.27 7/15/2020689,800 shares $1.22 million +60.2%N/A1.1 $1.77 6/30/2020430,600 shares $736,326.00 +7.3%N/A0.8 $1.71 6/15/2020401,200 shares $649,944.00 +432.8%N/A0.8 $1.62 5/29/202075,300 shares $146,082.00 +2.5%N/A0.2 $1.94 5/15/202073,500 shares $118,335.00 +25.6%N/A0.4 $1.61 4/30/202058,500 shares $98,280.00 -5.8%N/A0.9 $1.68 4/15/202062,100 shares $108,414.18 +37.4%N/A0.9 $1.75 3/31/202045,200 shares $71,416.00 -14.7%N/A0.6 $1.58 3/13/202053,000 shares $89,570.00 -19.7%N/A1.1 $1.69 BLRX Short Interest - Frequently Asked Questions What is BioLineRx's current short interest? Short interest is the volume of BioLineRx shares that have been sold short but have not yet been closed out or covered. As of February 15th, traders have sold 216,400 shares of BLRX short. 5.85% of BioLineRx's shares are currently sold short. Learn More on BioLineRx's current short interest. What is a good short interest ratio for BioLineRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLRX shares currently have a short interest ratio of 1.0. Learn More on BioLineRx's short interest ratio. Which institutional investors are shorting BioLineRx? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioLineRx: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for BioLineRx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.85% of BioLineRx's floating shares are currently sold short. Is BioLineRx's short interest increasing or decreasing? BioLineRx saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 216,400 shares, an increase of 76.1% from the previous total of 122,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BioLineRx's float size? BioLineRx currently has issued a total of 3,329,000 shares. Some of BioLineRx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioLineRx currently has a public float of 3,700,000 shares. How does BioLineRx's short interest compare to its competitors? 5.85% of BioLineRx's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioLineRx: Spero Therapeutics, Inc. (0.83%), FibroBiologics, Inc. (7.33%), Kezar Life Sciences, Inc. (1.94%), Dyadic International, Inc. (0.59%), Atara Biotherapeutics, Inc. (18.09%), Lantern Pharma Inc. (2.77%), Xilio Therapeutics, Inc. (10.74%), Barinthus Biotherapeutics plc (0.04%), 23andMe Holding Co. (8.79%), FibroGen, Inc. (2.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), MicroStrategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks. What does it mean to sell short BioLineRx stock? Short selling BLRX is an investing strategy that aims to generate trading profit from BioLineRx as its price is falling. BLRX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioLineRx? A short squeeze for BioLineRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BLRX, which in turn drives the price of the stock up even further. How often is BioLineRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLRX, twice per month. The most recent reporting period available is February, 15 2025. More Short Interest Resources from MarketBeat Related Companies SPRO Short Interest FBLG Short Interest KZR Short Interest DYAI Short Interest ATRA Short Interest LTRN Short Interest XLO Short Interest BRNS Short Interest ME Short Interest FGEN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BLRX) was last updated on 3/9/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLineRx Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLineRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLRX Stock Alerts